US Patent Issued to XWPharma on July 28 for "Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative" (California, Minnesota Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,090, issued on July 28, was assigned to XWPharma Ltd. (Grand Cayman, Cayman Islands).

"Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative" was invented by Daniel M. Canafax (Half Moon Bay, Calif.), William W. Xiang (Fremont, Calif.), Leonard Blum (Edina, Minn.) and Jia-Ning Xiang (Fremont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions comprising an immediate release component comprising 4-((L-valyl)oxy)butanoic acid and a modified release component comprising 4-((L-valyl)oxy)butanoic acid and the pharmacokinetics of 4-((L-valyl)oxy)butanoic acid and Gamma-hydroxybutyrate fo...